03/03/2013 11:54:00

EADS CEO: Chances to Exceed Official Profitability Target-Report

The chief executive officer of European Aeronautic Defence & Space Co. (EAD.FR) sees chances for a higher than officially targeted return on sales, according to a preview in Focus magazine on Sunday.

In the financial year 2012, EADS posted earnings before interest and taxes ratio of 5.3% of revenues, recorded before one-off items, according to EADS' 2012 annual results. Officially, EADS is seeking to boost this 5.3% to 10% by 2015, the magazine said.

"That's not necessarily the peak," CEO Thomas Enders said, seeing "very good potential" especially in the commercial aircraft business, the magazine reported.

EADS units are still far from the 10% return target that requires fierce cost control, the magazine said, adding that serious problems may not appear especially during the development and production of new jets if the company want to earn more in the future.

Magazine website: www.focus.de

Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com

(END) Dow Jones Newswires

March 03, 2013 06:54 ET (11:54 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
26 Jul
 
Pouli,   Forum er i den grad domineret af børn, studerende, ludomaner, buffet-wannabees and what hav..
24
28 Jul
GEN
Der er lidt nyt fra Morphosys angående deres CD38 antistof - det lader heldigvis til at gå lidt lang..
17
30 Jul
 
Jeg er helt vild med vendingen "og investere mine penge i aktier ud fra en strategi jeg mener vil sl..
14
29 Jul
FING-B
XO/Sologstrand, Mackeith, Vildum, Swiftnick og andre FING-skeptikere   1) Er vi enige i, at markedet..
13
28 Jul
 
Dejligt at der er nogen som kan svare "sobert" på et stillet spørgsmål.   Svaret kan indeholde ironi..
12
29 Jul
BIOPOR
I er tydeligvis enormt begavede og succesfulde alle tre. Men kunne det være muligt for jer at måle j..
10
27 Jul
 
Jeg har opdateret mine udbyttelister med tilbagekøb.   http://www.proinvestor.com/boards/69564/    
10
00:37
GEN
Rygterne siger At den hemmelige partner er Gilead. De er jo et af vardens største biotekselskaber de..
9
28 Jul
VELO
28/07/2014 08:30:00 - OMX Copenhagen, News     VELO: Veloxis Pharmaceuticals A/S - Envarsus ® får ..
9
27 Jul
BIOPOR
Alpe, det jeg skriver, skal absolut ikke ses som en meget udenoms forklaring.   men, trist du kun fo..
8

Tech Companies Send Criticism Along With NSA-Related Data -- Update

04/02/2014 00:06:00
By Danny Yadron Technology companies including Google Inc. and Microsoft Corp. released new figures on the amount of data requests they received from U.S. ..

U.S. Hot Stocks: Hot Stocks to Watch

03/02/2014 14:07:00
Among the companies with shares expected to actively trade in Monday's session is Herbalife Ltd. (HLF). Herbalife Ltd. (HLF) raised its fourth-quarter outl..

Pfizer Study Meets Primary Endpoints

03/02/2014 13:05:00
Pfizer Inc. (PFE) said Monday that a Phase 2 trial of its advanced breast cancer treatment met its primary endpoint. Pfizer said a study comparing the effec..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
[Iliad Press Release] Iliad confirms its interest in T-Mobile US
2
GSK and Genmab Announce Positive Interim Result for Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL
3
L'Oréal: News Release: "First-half 2014 results"
4
Ashland Inc. reports preliminary financial results for the third quarter of fiscal 2014
5
SOCIETE GENERALE: QUARTERLY FINANCIAL INFORMATION, Q2-2014
Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
01 August 2014 16:52:45
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20140731.2 - EUROWEB3 - 2014-08-01 17:52:45 - 2014-08-01 16:52:45 - 1000 - Website: OKAY